Purdue Pharma

May 8, 2007 -- Boise – Idaho Attorney General Lawrence Wasden and the Attorneys General of 25 states and the District of Columbia reached a settlement with Purdue Pharma (“Purdue”) which will prohibit the practice of “off label” marketing of the prescription drug OxyContin and may reduce the incidence of addiction.    » read more »

May 8, 2007 -- Connecticut Attorney General Richard Blumenthal and Department of Consumer Protection (DCP) Commissioner Jerry Farrell, Jr. today announced the maker of OxyContin has agreed to stop alleged illegal marketing of the drug and take additional steps against abuse and diversion.

The settlement also requires Purdue Pharma, LLC, of Stamford to pay Connecticut $719,500, part of $19.5 million it will pay Connecticut, 25 other states and the District of Columbia. Connecticut will allocate $100,000 from the settlement to help fund a state prescription drug monitoring system.    » read more »